Zugriffe | |
---|---|
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial | 27 |
November 2023 | Dezember 2023 | Januar 2024 | Februar 2024 | März 2024 | April 2024 | Mai 2024 | |
---|---|---|---|---|---|---|---|
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial | 0 | 0 | 4 | 2 | 2 | 2 | 1 |
Zugriffe | |
---|---|
2021_Goerling_etal.pdf | 72 |